Evidence map›Paper›PMID 20674795›Full record

ReviewInfectious disease clinics of North America2010

Severe acute respiratory syndrome and coronavirus.

David S C Hui, Paul K S Chan

Registry-linked trialAbstract readCase ReportsReview
In one paragraph

Review in Infectious disease clinics of North America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04684550 (Randomized Controlled Clinical Study), which is not on this map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04684550 phase2 / phase3withdrawnnot on this mapstarted 2021, after this paper: background citation

Randomized Controlled Clinical Study (RCT) Phase 3 of the Safety and Efficacy of Hypochlorous Acid in the Prophylaxis of Healthcare Personnel at High Risk of Infection by SARS-CoV2 (COVID19) Versus Placebo

TypeinterventionalSponsorHospital Universitario San IgnacioRan2021 to 2021Enrolled0ConditionsSARS-CoV Infection, Covid19, Infection ViralArmsStabilized hypochlorous acid, Placebo
3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review a brief history of coronaviruses in Thailand.Journal of virological methods · 2021
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. COVID-19: from epidemiology to treatment.European heart journal · 2020
    Article
  19. COVID-19 in long-term care facilities: An upcoming threat that cannot be ignored.Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

David S C HuiDivision of Respiratory Medicine, Stanley Ho Center for Emerging Infectious Diseases, Prince of Wales Hospital, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong, China. dschui@cuhk.edu.hk
Paul K S Chan

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe acute respiratory syndrome (SARS) is a highly infectious disease with a significant morbidity and mortality. Respiratory failure is the major complication, and patients may progress to acute respiratory distress syndrome. Health care workers are particularly vulnerable to SARS. SARS has the potential of being converted from droplet to airborne transmission. There is currently no proven effective treatment of SARS, so early recognition, isolation, and stringent infection control are the key to controlling this highly contagious disease. Horseshoe bats are implicated in the emergence of novel coronavirus infection in humans. Further studies are needed to examine host genetic markers that may predict clinical outcome.

Indexed as

Disease OutbreaksAnimalsAntiviral AgentsCommunicable Diseases, EmergingHumansImmunologic FactorsImmunotherapyMaleMiddle AgedSevere Acute Respiratory SyndromeSevere acute respiratory syndrome-related coronavirusAntiviral AgentsImmunologic Factors

Identifiers

PMID20674795
PMCPMC7127710

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.